Ligand Pharmaceuticals Inc (NASDAQ:LGND)

58.89
Delayed Data
As of 3:59pm ET
 +0.58 / +0.99%
Today’s Change
49.24
Today|||52-Week Range
85.70
-11.84%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.0B

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.

Contact Information

Ligand Pharmaceuticals, Inc.
3911 Sorrento Valley Boulevard
San Diego California 92121
P:(858) 550-7500
Investor Relations:
(858) 550-7766

Employees

Shareholders

Mutual fund holders60.68%
Other institutional32.76%
Individual stakeholders31.53%

Top Executives

Todd C. DavisChief Executive Officer & Director
Matthew Edward KorenbergPresident & Chief Operating Officer
Octavio EspinozaChief Financial Officer
Simon LatimerInvestors Relations Manager
Audrey Warfield-GrahamChief People Officer